VITRASE - 24208-002-01 - (hyaluronidase, ovine)

Alphabetical Index


Drug Information of VITRASE

Product NDC: 24208-002
Proprietary Name: VITRASE
Non Proprietary Name: hyaluronidase, ovine
Active Ingredient(s): 200    [USP'U]/mL & nbsp;   hyaluronidase, ovine
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of VITRASE

Product NDC: 24208-002
Labeler Name: Bausch & Lomb Incorporated
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021640
Marketing Category: NDA
Start Marketing Date: 20050201

Package Information of VITRASE

Package NDC: 24208-002-01
Package Description: 6 VIAL, SINGLE-USE in 1 CARTON (24208-002-01) > 1.2 mL in 1 VIAL, SINGLE-USE

NDC Information of VITRASE

NDC Code 24208-002-01
Proprietary Name VITRASE
Package Description 6 VIAL, SINGLE-USE in 1 CARTON (24208-002-01) > 1.2 mL in 1 VIAL, SINGLE-USE
Product NDC 24208-002
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name hyaluronidase, ovine
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20050201
Marketing Category Name NDA
Labeler Name Bausch & Lomb Incorporated
Substance Name HYALURONIDASE, OVINE
Strength Number 200
Strength Unit [USP'U]/mL
Pharmaceutical Classes Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient]

Complete Information of VITRASE


General Information